Impact of 2017 American Society of Clinical Oncology Guidelines on Postanthracycline Cardiac Surveillance Practices
Authors' conclusion
Release of the ASCO guidelines was not associated with changes in echocardiogram frequency with under half of patients receiving an echocardiogram within 18 months following chemotherapy initiation.
Study context
- Population
- Patients receiving anthracycline chemotherapy
- Exposure
- Before vs after release of the 2017 ASCO guidelines
- Outcome
- Echocardiogram frequency (postanthracycline surveillance echocardiography)
- Follow-up
- Within 18 months following chemotherapy initiation
Main finding
As reported in the abstract
Echocardiogram frequency
- Release of the ASCO guidelines not associated with changes in echocardiogram frequency
- Under half of patients received an echocardiogram within 18 months following chemotherapy initiation
Observational data: associations, not effects.
Original publication
Impact of 2017 American Society of Clinical Oncology Guidelines on Postanthracycline Cardiac Surveillance Practices. JACC Adv. Published 9 December 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →